Cohere is trialing a new platform called North, which makes it easier for companies to deploy the hottest AI trend of the year: AI agents.

From AI-driven defense to evolving ransomware tactics, here's what cybersecurity industry leaders and experts are preparing for this year.

Wedbush analyst Dan Ives remains bullish and expects Tesla's market cap to hit $2 trillion in 2025, saying the coming four years will be a "total game changer" for Tesla. He expects the Trump administration to fast-track full self-driving (FSD), paving the way for the company's robotaxi agenda.

A 'binary big bang' occurred when AI foundation models cracked the natural language barrier, kickstarting a shift in our technology systems: how we design them, use them, and how they operate.

Indeed, Musk suggested that synthetic data — data generated by AI models themselves — is the path forward. “The only way to supplement [real-world data] is with synthetic data, where the AI creates [training data],” he said. “With synthetic data … [AI] will sort of grade itself and go through this process of self-learning.”

Taiwan Semiconductor Manufacturing Co. posted December quarter revenue that topped analyst estimates as the company continues to get a boost from the AI boom. TSMC manufacturers semiconductors for some of the world's biggest companies from Apple to Nvidia.

AI promises to change the world around us, and we all need to reflect on how this will affect the many aspects of our daily lives.

Generative AI projects will move from pilot phase to production for many companies this year, which means the workforce will be affected in ways never before imagined, says Sarah Hoffman, director of AI research at AlphaSense.

It was almost a year before a handful of Chinese AI chatbots received government approval for public release. Some questioned whether China’s stance on censorship might hobble the country’s AI ambitions.

Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to treat a rare progressive lung disease for which there is no known cause or cure. The new drug has yet to be approved, but in small clinical trials has shown impressive efficacy in treating idiopathic pulmonary fibrosis (IPF).

An AI expert argues AI progress hasn’t stalled, it’s become invisible, which could leave us unprepared for the future.

A study published today in the journal Nature by researchers at Columbia University described a new medical AI model that they say can accurately predict the activity of genes at the cellular level. In theory,